accountPfizer's announcement on Jan. 26 that it will buy Wyeth (WYE) for $68 billion in cash and stock called up visions of past Pfizer acquisitions for many pharmaceutical executives—and some of those visions resembled nightmares. But Pfizer CEO Jeffrey Kindler,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer CEO: Wyeth Takeover Will Be Different
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account